KRAS and infantile convulsions and choreoathetosis: Signaling pathways, drivers of carcinogenesis and potential targets for therapies in iCCA, include KRAS/MAPK, EGFR, IL-6/STAT, IDH1/2, FGFR2 and MET signaling.